WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $45.2 million in its first quarter.
The Watertown, Massachusetts-based company said it had a loss of 65 cents per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 65 cents per share.
The drug delivery technology company posted revenue of $24.5 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $5.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
